{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:28:32Z","timestamp":1793845712994,"version":"4.6.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Key Clinical Research Initiative Program of Union Hospital","award":["2025LCYJ06"],"award-info":[{"award-number":["2025LCYJ06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00134-026-08381-x","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T07:21:04Z","timestamp":1774941664000},"page":"1001-1011","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Short-term light sedation with remimazolam besylate versus propofol in the ICU (SHOSREB): a multicentre, randomized, single-blind, controlled trial"],"prefix":"10.1007","volume":"52","author":[{"given":"Xiaobo","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingye","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailian","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengming","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouzhi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuming","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renhua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongwen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songzan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deliang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqing","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4097-6131","authenticated-orcid":false,"given":"You","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"8381_CR1","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","volume":"46","author":"JW Devlin","year":"2018","unstructured":"Devlin JW, Skrobik Y, G\u00e9linas C et al (2018) Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the icu. Crit Care Med 46:e825\u2013e873. https:\/\/doi.org\/10.1097\/CCM.0000000000003299","journal-title":"Crit Care Med"},{"key":"8381_CR2","doi-asserted-by":"publisher","first-page":"e711","DOI":"10.1097\/CCM.0000000000006574","volume":"53","author":"K Lewis","year":"2025","unstructured":"Lewis K, Balas MC, Stollings JL et al (2025) A focused update to the clinical practice guidelines for the prevention and management of pain, anxiety, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the icu. Crit Care Med 53:e711\u2013e727. https:\/\/doi.org\/10.1097\/CCM.0000000000006574","journal-title":"Crit Care Med"},{"key":"8381_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bja.2022.02.040","volume":"129","author":"D Chae","year":"2022","unstructured":"Chae D, Kim H-C, Song Y et al (2022) Pharmacodynamic analysis of intravenous bolus remimazolam for loss of consciousness in patients undergoing general anaesthesia: a randomised, prospective, double-blind study. Br J Anaesth 129:49\u201357. https:\/\/doi.org\/10.1016\/j.bja.2022.02.040","journal-title":"Br J Anaesth"},{"key":"8381_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.bja.2021.05.027","volume":"127","author":"T St\u00f6hr","year":"2021","unstructured":"St\u00f6hr T, Colin PJ, Ossig J et al (2021) Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment. Br J Anaesth 127:415\u2013423. https:\/\/doi.org\/10.1016\/j.bja.2021.05.027","journal-title":"Br J Anaesth"},{"key":"8381_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s44254-025-00090-w","volume":"3","author":"TG Hansen","year":"2025","unstructured":"Hansen TG, Engelhardt T (2025) Remimazolam in children: a comprehensive narrative review. Anesthesiol Perioper Sci 3:7. https:\/\/doi.org\/10.1007\/s44254-025-00090-w","journal-title":"Anesthesiol Perioper Sci"},{"key":"8381_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1101728","author":"C-C Ko","year":"2023","unstructured":"Ko C-C, Hung K-C, Illias AM et al (2023) The use of remimazolam versus propofol for induction and maintenance of general anesthesia: A systematic review and meta-analysis. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2023.1101728","journal-title":"Front Pharmacol"},{"key":"8381_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00228-024-03624-6","volume":"80","author":"W Ahmer","year":"2024","unstructured":"Ahmer W, Imtiaz S, Alam DM et al (2024) Remimazolam versus propofol for sedation in gastrointestinal endoscopy and colonoscopy within elderly patients: a meta-analysis of randomized controlled trials. Eur J Clin Pharmacol 80:493\u2013503. https:\/\/doi.org\/10.1007\/s00228-024-03624-6","journal-title":"Eur J Clin Pharmacol"},{"key":"8381_CR8","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.bja.2024.02.005","volume":"132","author":"EC Barbosa","year":"2024","unstructured":"Barbosa EC, Esp\u00edrito Santo PA, Baraldo S, Meine GC (2024) Remimazolam versus propofol for sedation in gastrointestinal endoscopic procedures: a systematic review and meta-analysis. Br J Anaesth 132:1219\u20131229. https:\/\/doi.org\/10.1016\/j.bja.2024.02.005","journal-title":"Br J Anaesth"},{"key":"8381_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1409495","author":"X Liu","year":"2025","unstructured":"Liu X, Zhang L, Zhao L et al (2025) Comparison of the safety of remimazolam and propofol during general anesthesia in elderly patients: systematic review and meta-analysis. Front Med. https:\/\/doi.org\/10.3389\/fmed.2025.1409495","journal-title":"Front Med"},{"key":"8381_CR10","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1097\/CM9.0000000000002243","volume":"135","author":"Y Tang","year":"2022","unstructured":"Tang Y, Yang X, Shu H et al (2022) Remimazolam besylate for sedation of postoperative patients in intensive care units: a phase I, open label, dose-finding study. Chin Med J (Engl) 135:2134\u20132136. https:\/\/doi.org\/10.1097\/CM9.0000000000002243","journal-title":"Chin Med J (Engl)"},{"key":"8381_CR11","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.clinthera.2020.02.006","volume":"42","author":"X Chen","year":"2020","unstructured":"Chen X, Sang N, Song K et al (2020) Psychomotor Recovery Following Remimazolam-induced Sedation and the Effectiveness of Flumazenil as an Antidote. Clin Ther 42:614\u2013624. https:\/\/doi.org\/10.1016\/j.clinthera.2020.02.006","journal-title":"Clin Ther"},{"key":"8381_CR12","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1213\/ANE.0b013e3182a705ae","volume":"117","author":"MT Worthington","year":"2013","unstructured":"Worthington MT, Antonik LJ, Goldwater DR et al (2013) A phase Ib, dose-finding study of multiple doses of remimazolam (cns 7056) in volunteers undergoing colonoscopy. Anesth Analg 117:1093\u20131100. https:\/\/doi.org\/10.1213\/ANE.0b013e3182a705ae","journal-title":"Anesth Analg"},{"key":"8381_CR13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4097\/kja.22297","volume":"75","author":"S-H Kim","year":"2022","unstructured":"Kim S-H, Fechner J (2022) Remimazolam \u2013 current knowledge on a new intravenous benzodiazepine anesthetic agent. Korean J Anesthesiol 75:307\u2013315. https:\/\/doi.org\/10.4097\/kja.22297","journal-title":"Korean J Anesthesiol"},{"key":"8381_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13054-022-04168-w","volume":"26","author":"Y Tang","year":"2022","unstructured":"Tang Y, Yang X, Yu Y et al (2022) Remimazolam besylate versus propofol for long-term sedation during invasive mechanical ventilation: a pilot study. Crit Care 26:279. https:\/\/doi.org\/10.1186\/s13054-022-04168-w","journal-title":"Crit Care"},{"key":"8381_CR15","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/s13054-023-04760-8","volume":"27","author":"Y Tang","year":"2023","unstructured":"Tang Y, Gao X, Xu J et al (2023) Remimazolam besylate versus propofol for deep sedation in critically ill patients: a randomized pilot study. Crit Care 27:474. https:\/\/doi.org\/10.1186\/s13054-023-04760-8","journal-title":"Crit Care"},{"key":"8381_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12871-025-02903-8","volume":"25","author":"Y Li","year":"2025","unstructured":"Li Y, Yuan Y, Zhou J, Ma L (2025) Effect of remimazolam besylate on elderly patients with mechanical ventilation: a single-center randomized controlled study. BMC Anesthesiol 25:65. https:\/\/doi.org\/10.1186\/s12871-025-02903-8","journal-title":"BMC Anesthesiol"},{"key":"8381_CR17","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1007\/s12325-025-03268-7","volume":"42","author":"Y Tang","year":"2025","unstructured":"Tang Y, Shu H, Ren L et al (2025) Remimazolam besylate versus propofol for short-term sedation in critically ill patients receiving mechanical ventilation: protocol for a multicenter randomized non-inferior trial. Adv Ther 42:4081\u20134088. https:\/\/doi.org\/10.1007\/s12325-025-03268-7","journal-title":"Adv Ther"},{"key":"8381_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jointm.2025.12.002","author":"X Yang","year":"2026","unstructured":"Yang X, Fu S, Yu L et al (2026) Efficacy and safety of remimazolam besylate in patients receiving mechanical ventilation: A randomized phase IIa trial. J Intensive Med. https:\/\/doi.org\/10.1016\/j.jointm.2025.12.002","journal-title":"J Intensive Med"},{"key":"8381_CR19","unstructured":"World Health Organization. Anatomical Therapeutic Chemical (ATC) Classification. https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/atc-classification. Accessed 11 Feb 2023"},{"key":"8381_CR20","unstructured":"Us department of health and human services. Common terminology criteria for adverse events (ctcae) version 5.0. https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events\/ctcae-v5-8x11.pdf. Accessed 11 Feb 2023"},{"key":"8381_CR21","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jama.2012.304","volume":"307","author":"SM Jakob","year":"2012","unstructured":"Jakob SM, Ruokonen E, Grounds RM et al (2012) Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: Two randomized controlled trials. JAMA 307:1151\u20131160. https:\/\/doi.org\/10.1001\/jama.2012.304","journal-title":"JAMA"},{"key":"8381_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40560-023-00698-9","volume":"11","author":"M Doi","year":"2023","unstructured":"Doi M, Takahashi N, Nojiri R et al (2023) Efficacy, safety, and pharmacokinetics of MR13A11A, a generic of remifentanil, for pain management of japanese patients in the intensive care unit: A double-blinded, fentanyl-controlled, randomized, non-inferiority phase 3 study. J Intensive Care 11:51. https:\/\/doi.org\/10.1186\/s40560-023-00698-9","journal-title":"J Intensive Care"},{"key":"8381_CR23","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S2213-2600(21)00323-4","volume":"9","author":"A Meiser","year":"2021","unstructured":"Meiser A, Volk T, Wallenborn J et al (2021) Inhaled isoflurane via the anaesthetic conserving device versus propofol for sedation of invasively ventilated patients in intensive care units in germany and slovenia: An open-label, phase 3, randomised controlled, non-inferiority trial. Lancet Respir Med 9:1231\u20131240. https:\/\/doi.org\/10.1016\/S2213-2600(21)00323-4","journal-title":"Lancet Respir Med"},{"key":"8381_CR24","first-page":"138","volume":"29","author":"C Li","year":"2023","unstructured":"Li C, Gao Z, Chen H et al (2023) Remifentanil versus fentanyl for analgesia in mechanically ventilated patients: A multicenter, prospective, randomized, double-blind, parallel-group clinical trial. Altern Ther Health Med 29:138\u2013147","journal-title":"Altern Ther Health Med"},{"key":"8381_CR25","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1097\/CCM.0000000000005920","volume":"51","author":"Y Liu","year":"2023","unstructured":"Liu Y, Peng Z, Liu S et al (2023) Efficacy and safety of ciprofol sedation in ICU patients undergoing mechanical ventilation: A multicenter, single-blind, randomized, noninferiority trial. Crit Care Med 51:1318\u20131327. https:\/\/doi.org\/10.1097\/CCM.0000000000005920","journal-title":"Crit Care Med"},{"key":"8381_CR26","first-page":"682","volume":"90","author":"J D\u2019AndriaUrsoleo","year":"2024","unstructured":"D\u2019AndriaUrsoleo J, Licheri M, Barucco G et al (2024) Remimazolam for anesthesia and sedation in cardiac surgery and for cardiac patients undergoing non-cardiac surgery: A systematic-narrative hybrid review. Minerva Anestesiol 90:682\u2013693","journal-title":"Minerva Anestesiol"},{"key":"8381_CR27","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s00540-024-03358-w","volume":"38","author":"M Pieri","year":"2024","unstructured":"Pieri M, D\u2019Andria Ursoleo J, Di Prima AL et al (2024) Remimazolam for anesthesia and sedation in pediatric patients: A scoping review. J Anesth 38:692\u2013710. https:\/\/doi.org\/10.1007\/s00540-024-03358-w","journal-title":"J Anesth"},{"key":"8381_CR28","doi-asserted-by":"publisher","first-page":"101555","DOI":"10.1016\/j.accpm.2025.101555","volume":"44","author":"J D\u2019AndriaUrsoleo","year":"2025","unstructured":"D\u2019AndriaUrsoleo J, Bottussi A, Erdoes G et al (2025) Remimazolam for anesthesia in cardiac and noncardiac surgery A narrative literature review and synthesis. Anaesth Crit Care Pain Med 44:101555. https:\/\/doi.org\/10.1016\/j.accpm.2025.101555","journal-title":"Anaesth Crit Care Pain Med"},{"key":"8381_CR29","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/ALN.0000000000005348","volume":"142","author":"R Vellinga","year":"2025","unstructured":"Vellinga R, Koomen JV, Eleveld DJ et al (2025) Influence of remifentanil on the pharmacokinetics and pharmacodynamics of remimazolam in healthy volunteers. Anesthesiology 142:666\u2013679. https:\/\/doi.org\/10.1097\/ALN.0000000000005348","journal-title":"Anesthesiology"},{"key":"8381_CR30","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s40262-018-0672-3","volume":"57","author":"MM Sahinovic","year":"2018","unstructured":"Sahinovic MM, Struys MMRF, Absalom AR (2018) Clinical pharmacokinetics and pharmacodynamics of propofol. Clin Pharmacokinet 57:1539\u20131558. https:\/\/doi.org\/10.1007\/s40262-018-0672-3","journal-title":"Clin Pharmacokinet"},{"key":"8381_CR31","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.2147\/DDDT.S474854","volume":"18","author":"H Zhang","year":"2024","unstructured":"Zhang H, Li H, Zhao S, Bao F (2024) Remimazolam in general anesthesia: a comprehensive review of its applications and clinical efficacy. DDDT 18:3487\u20133498. https:\/\/doi.org\/10.2147\/DDDT.S474854","journal-title":"DDDT"},{"key":"8381_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1213\/ANE.0000000000007309","volume":"141","author":"Y-Y Xiao","year":"2025","unstructured":"Xiao Y-Y, Zou H-D, Qin X-N et al (2025) A comparison of remimazolam versus propofol on blood pressure changes during therapeutic endoscopic retrograde cholangiopancreatography: a randomized controlled trial. Anesth Analg 141:90\u201399. https:\/\/doi.org\/10.1213\/ANE.0000000000007309","journal-title":"Anesth Analg"},{"key":"8381_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12871-025-03156-1","volume":"25","author":"X Zhao","year":"2025","unstructured":"Zhao X, Xu H, Wang S et al (2025) Effect of propofol combined with remimazolam besylate on blood pressure during general anesthesia induction in patients undergoing gynecological laparoscopic surgery: single-centre randomized controlled trial. BMC Anesthesiol 25:273. https:\/\/doi.org\/10.1186\/s12871-025-03156-1","journal-title":"BMC Anesthesiol"},{"key":"8381_CR34","doi-asserted-by":"publisher","first-page":"6423","DOI":"10.2147\/DDDT.S532746","volume":"19","author":"Q Gu","year":"2025","unstructured":"Gu Q, Zeng D, Lin D et al (2025) Effect of remimazolam versus propofol on hemodynamics in elderly hypertensive patients undergoing gastroenteroscopy: a multicenter, randomized controlled clinical trial. Drug Des Dev Ther 19:6423\u20136434. https:\/\/doi.org\/10.2147\/DDDT.S532746","journal-title":"Drug Des Dev Ther"},{"key":"8381_CR35","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00540-020-02776-w","volume":"34","author":"M Doi","year":"2020","unstructured":"Doi M, Hirata N, Suzuki T et al (2020) Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial. J Anesth 34:491\u2013501. https:\/\/doi.org\/10.1007\/s00540-020-02776-w","journal-title":"J Anesth"},{"key":"8381_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-025-01548-7","author":"BT De Jong","year":"2025","unstructured":"De Jong BT, Eleveld DJ, Mason KP, Struys MMRF (2025) Clinical pharmacokinetics and pharmacodynamics of remimazolam. Clin Pharmacokinet. https:\/\/doi.org\/10.1007\/s40262-025-01548-7","journal-title":"Clin Pharmacokinet"},{"key":"8381_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2024.111644","volume":"99","author":"J D\u2019Andria Ursoleo","year":"2024","unstructured":"D\u2019Andria Ursoleo J, Bottussi A, Agosta VT, Monaco F (2024) Letter to the editor regarding \u201ceffect of remimazolam versus propofol on hypotension after anesthetic induction in patients undergoing coronary artery bypass grafting: A randomized controlled trial.\u201d J Clin Anesth 99:111644. https:\/\/doi.org\/10.1016\/j.jclinane.2024.111644","journal-title":"J Clin Anesth"},{"key":"8381_CR38","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1053\/j.jvca.2024.10.008","volume":"39","author":"F Monaco","year":"2025","unstructured":"Monaco F, Bottussi A, Barucco G, D\u2019Andria Ursoleo J (2025) Remimazolam in cardiac anesthesia: Not so \u201cultra-short acting\u201d after all. J Cardiothorac Vasc Anesth 39:327\u2013328. https:\/\/doi.org\/10.1053\/j.jvca.2024.10.008","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"8381_CR39","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10928-020-09712-1","volume":"47","author":"A Bienert","year":"2020","unstructured":"Bienert A, Sobczy\u0144ski P, M\u0142odawska K et al (2020) The influence of cardiac output on propofol and fentanyl pharmacokinetics and pharmacodynamics in patients undergoing abdominal aortic surgery. J Pharmacokinet Pharmacodyn 47:583\u2013596. https:\/\/doi.org\/10.1007\/s10928-020-09712-1","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"8381_CR40","doi-asserted-by":"publisher","first-page":"101510","DOI":"10.1016\/j.accpm.2025.101510","volume":"44","author":"N Grillot","year":"2025","unstructured":"Grillot N, Vourc\u2019h M, Hourmant Y et al (2025) A phase 2 open-label pilot study of remimazolam for sedation in critically ill patients. Anaesth Crit Care Pain Med 44:101510. https:\/\/doi.org\/10.1016\/j.accpm.2025.101510","journal-title":"Anaesth Crit Care Pain Med"},{"key":"8381_CR41","doi-asserted-by":"publisher","first-page":"1526266","DOI":"10.3389\/fphar.2025.1526266","volume":"16","author":"J Chen","year":"2025","unstructured":"Chen J, Wang X, Chen D et al (2025) Population pharmacokinetic analysis of remimazolam after continuous infusion for sedation in critically ill patients. Front Pharmacol 16:1526266. https:\/\/doi.org\/10.3389\/fphar.2025.1526266","journal-title":"Front Pharmacol"},{"key":"8381_CR42","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1056\/NEJMoa1906759","volume":"382","author":"HT Olsen","year":"2020","unstructured":"Olsen HT, Nedergaard HK, Str\u00f8m T et al (2020) Nonsedation or light sedation in critically ill, mechanically ventilated patients. N Engl J Med 382:1103\u20131111. https:\/\/doi.org\/10.1056\/NEJMoa1906759","journal-title":"N Engl J Med"},{"key":"8381_CR43","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1345\/aph.1Q525","volume":"46","author":"S Devabhakthuni","year":"2012","unstructured":"Devabhakthuni S, Armahizer MJ, Dasta JF, Kane-Gill SL (2012) Analgosedation: A paradigm shift in intensive care unit sedation practice. Ann Pharmacother 46:530\u2013540. https:\/\/doi.org\/10.1345\/aph.1Q525","journal-title":"Ann Pharmacother"},{"key":"8381_CR44","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00134-008-1328-9","volume":"35","author":"FW Rozendaal","year":"2009","unstructured":"Rozendaal FW, Spronk PE, Snellen FF et al (2009) Remifentanil-propofol analgo-sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: A centre randomised, cross-over, open-label study in the netherlands. Intensive Care Med 35:291\u2013298. https:\/\/doi.org\/10.1007\/s00134-008-1328-9","journal-title":"Intensive Care Med"},{"key":"8381_CR45","doi-asserted-by":"publisher","first-page":"R91","DOI":"10.1186\/cc4939","volume":"10","author":"B Muellejans","year":"2006","unstructured":"Muellejans B, Matthey T, Scholpp J, Schill M (2006) Sedation in the intensive care unit with remifentanil\/propofol versus midazolam\/fentanyl: A randomised, open-label, pharmacoeconomic trial. Crit Care 10:R91. https:\/\/doi.org\/10.1186\/cc4939","journal-title":"Crit Care"},{"key":"8381_CR46","doi-asserted-by":"publisher","first-page":"1139872","DOI":"10.3389\/fphar.2023.1139872","volume":"14","author":"X Yang","year":"2023","unstructured":"Yang X, Tang Y, Du R et al (2023) Long-term sedation with remimazolam besylate versus propofol in critically ill patients during invasive mechanical ventilation: a study protocol for a multicenter randomized non-inferior trial. Front Pharmacol 14:1139872. https:\/\/doi.org\/10.3389\/fphar.2023.1139872","journal-title":"Front Pharmacol"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08381-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-026-08381-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08381-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T15:41:28Z","timestamp":1780933288000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-026-08381-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["8381"],"URL":"https:\/\/doi.org\/10.1007\/s00134-026-08381-x","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"24 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This clinical study was initiated by Yichang Humanwell Pharmaceutical Co., Ltd. to obtain approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration of China for the use of remimazolam besylate (Ruima\u00ae) as a sedative in mechanically ventilated ICU patients. LS and CW are employed by Yichang Humanwell Pharmaceutical Co. Ltd. XY and YS received drugs for free for investigator-initiated trials from Yichang Humanwell Pharmaceutical Co. Ltd. All the authors declare no other competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The trial was approved by the ethics board of the leading site (Union Hospital, Tongji Medical College, Huazhong University of Science and Technology: 2021\u20131069-01) and every participating site.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all the participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}